Viewing Study NCT05795920


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-04-15 @ 2:49 PM
Study NCT ID: NCT05795920
Status: UNKNOWN
Last Update Posted: 2023-04-03
First Post: 2023-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic Cancer
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module